18-May-2023
New Trinity Delta Research Report – Two key Phase II results on track for next 12 months
11-May-2023
New Trinity Delta Lighthouse Report – ROCK solid start in cancer-associated fibrosis
02-Mar-2023
New Trinity Delta Lighthouse Report – Recommended all share combination with Jounce
09-Feb-2023
New Trinity Delta Lighthouse Report – RXC007 recruitment scales up; data now Q124
20-Dec-2022
New Trinity Delta Lighthouse Report – Laying the foundations for further delivery in 2023
07-Oct-2022
New Trinity Delta Research Report – New data draws attention to promising fibrosis assets
29-Jun-2022
New Trinity Delta Research Report – All the ingredients for success now in place
15-Jun-2022
New Trinity Delta Lighthouse Research Report – Jazz Pharmaceuticals $5m milestone triggered
07-Jun-2022
New Trinity Delta Lighthouse Research Report – £34.3m raise extends runway through key data points
30-Mar-2022
New Trinity Delta Research Report – RXC008 nominated as GI-ROCK drug candidate